Rapid Micro Biosystems, Inc. (RPID)
0.5904
-0.03
(-4.77%)
USD |
NASDAQ |
Nov 06, 10:24
Rapid Micro Biosystems Enterprise Value : 34.56M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 34.56M |
| November 04, 2026 | 37.62M |
| November 03, 2026 | 38.15M |
| November 02, 2026 | 38.69M |
| October 30, 2026 | 40.35M |
| October 29, 2026 | 43.00M |
| October 28, 2026 | 43.55M |
| October 27, 2026 | 42.92M |
| October 26, 2026 | 42.80M |
| October 23, 2026 | 42.55M |
| October 22, 2026 | 43.60M |
| October 21, 2026 | 44.36M |
| October 20, 2026 | 42.14M |
| October 19, 2026 | 42.23M |
| October 16, 2026 | 41.77M |
| October 15, 2026 | 45.80M |
| October 14, 2026 | 44.41M |
| October 13, 2026 | 47.24M |
| October 12, 2026 | 47.49M |
| October 09, 2026 | 48.22M |
| October 08, 2026 | 46.63M |
| October 07, 2026 | 48.43M |
| October 06, 2026 | 50.68M |
| October 05, 2026 | 52.36M |
| October 02, 2026 | 49.55M |
| Date | Value |
|---|---|
| October 01, 2026 | 49.60M |
| September 30, 2026 | 55.04M |
| September 29, 2026 | 57.54M |
| September 28, 2026 | 58.29M |
| September 25, 2026 | 59.04M |
| September 24, 2026 | 59.04M |
| September 23, 2026 | 59.04M |
| September 22, 2026 | 60.54M |
| September 21, 2026 | 60.04M |
| September 18, 2026 | 59.54M |
| September 17, 2026 | 58.04M |
| September 16, 2026 | 59.04M |
| September 15, 2026 | 61.04M |
| September 14, 2026 | 62.04M |
| September 11, 2026 | 65.04M |
| September 10, 2026 | 63.54M |
| September 09, 2026 | 64.04M |
| September 08, 2026 | 64.54M |
| September 04, 2026 | 69.03M |
| September 03, 2026 | 72.53M |
| September 02, 2026 | 73.03M |
| September 01, 2026 | 78.53M |
| August 31, 2026 | 79.53M |
| August 28, 2026 | 82.02M |
| August 27, 2026 | 84.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.63B |
| Bio-Rad Laboratories, Inc. | 9.617B |
| Bruker Corp. | 10.48B |
| Danaher Corp. | 181.32B |
| Harvard Bioscience, Inc. | 76.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.92M |
| Revenue (Quarterly) | 8.054M |
| Total Expenses (Quarterly) | 20.98M |
| EPS Diluted (Quarterly) | -0.2673 |
| Gross Profit Margin (Quarterly) | 15.05% |
| Profit Margin (Quarterly) | -160.5% |
| Earnings Yield | -189.3% |
| Normalized Earnings Yield | -189.74 |